FAIR had the great opportunity to present its objectives and preliminary findings in a full symposium at the European Respiratory Society (ERS) Congress in Vienna, Austria from September 7-11, 2024.
The symposium, Flagellin aerosol therapy as an immunomodulatory adjunct to the antibiotic treatment of drug-resistant bacterial pneumonia, presented the progression of the FAIR project, following its trajectory from preclinical investigations to translational development. The presentations were delivered by four key investigators of the FAIR project: Jean-Claude Sirard (Lille, France), Nathalie Heuzé-Vourc'h (Tours, France), Antoine Guillon (Tours, France) and Erik Michels (Amsterdam, Netherlands).
The recoding of the session is now freely available. Watch now.
The next event organised by FAIR and hosted by ERS is the online course on “Nebulisation of drugs for treatment of respiratory infections and disease” which will take place on February 25, 2025. The full programme and registration form is available under this link.